Showing results (261-270 of 378) with videos related to

Sort By:
Pageof 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancerTakeshi Shimamura, Zhao Chen, Margaret Soucheray, et al.
Oncotarget|September 18, 2014
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastomaNathan F Moore, Anna M Azarova, Namrata Bhatnagar, et al.
Cytotherapy|March 2, 2024
Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantationHannah Major-Monfried, Kinga Hosszu, Devin P McAvoy, et al.
Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2019
Mechanisms by which sialylated milk oligosaccharides impact bone biology in a gnotobiotic mouse model of infant undernutritionCarrie A Cowardin, Philip P Ahern, Vanderlene L Kung, et al.
Cytotherapy|February 13, 2024
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patientsMadhavi Lakkaraja, Audrey Mauguen, Farid Boulad, et al.
Nature Medicine|March 16, 2010
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activityDouglas W McMillin, Jake Delmore, Ellen Weisberg, et al.
Leukemia|April 4, 2012
Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitorsE Weisberg, Q Liu, Erik Nelson, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier caseBirgit Knoechel, Ami Bhatt, Li Pan, et al.
The Journal of Biological Chemistry|June 14, 2005
Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanismMaofu Fu, Chenguang Wang, Mahadev Rao, et al.
Pageof 38